Yüksel Ürün: The U.S. FDA has approved pembrolizumab in combination with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer

Yüksel Ürün, Professor at the Department of Medical Oncology at the Ankara University School of Medicine, shared on X/Twitter:

“The U.S. FDA has approved pembrolizumab in combination with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer. This decision follows the PFS benefit shown in the KEYNOTE-A18 trial.
OS data were not mature!
Reminding: the best way to treat cervical cancer is PREVENTION!!!!”

View additional information.
Source: Yüksel Ürün/X